openPR Logo
Press release

Scientific Conference Song: A World Without AIDS

11-05-2011 03:53 PM CET | Health & Medicine

Press release from: General Hospital

The organizers of the 2012 ISHEID announce the release of a song dedicated to the fight against HIV and AIDS.

Toulon, Var, France, November 04, 2011 -- The ISHEID (International Symposium on HIV & Emerging Infectious Diseases) will be held in Marseilles (France), 23-25 May 2012. This scientific meeting will welcome more than 1,500 participants from all over the world, including researchers, doctors, and activists, all united for a cause: “Searching for an HIV Cure”.

Dan Bull, a renowned UK singer, has just released his last title, “A world without AIDS”, dedicated to the 2012 ISHEID.

"His song strongly tells what AIDS is, the stigmatization coming from it, and the commitment of researchers to finally find a cure" said Alain Lafeuillade, Chair of the ISHEID.

The song can be downloaded free of charge on the meeting website: www.isheid.com

The ISHEID meeting will cover the topic of HIV cure in different sessions, including sessions on the mechanisms of HIV persistence, reservoirs maintenance and acute HIV infection. The Steering Committee contains the main international leaders in the field including Pr Gatell (Spain), Pr Vella (Italy), Pr Delfraissy (France), Pr Stellbrink (Germany).

Currently, HIV infects more than 34 million individuals worldwide and more than 7,000 new cases of infection occur daily. Most patients in resource-poor areas do not have access to antiretroviral therapy or are on a failing first line regimen. Both an anti-HIV vaccine, for those who are not yet infected, and a cure for those who already are, would be the only way to stop the pandemic.

HIV cure is the big challenge of the next decade. Thanks to majors advances achieved in the last two years, we now have get a better understanding of the mechanisms allowing HIV latency in reservoir cells, and new therapeutic approaches trying to eradicate this retrovirus have reached clinical testing. First results of these trials will be presented at the ISHEID.

About us: Alain Lafeuillade is the chair of the International Symposium on HIV & Emerging Infectious Diseases, Congress Center, Marseilles, France, May 23-25, 2012

Contact: Alain Lafeuillade, MD - Ph: 33-4-94616340 - Email: lafeuillade@orange.fr

The organizers of the 2012 ISHEID announce the release of a song dedicated to the fight against HIV and AIDS.

Contact:
Alain Lafeuillade
General Hospital
Toulon, 83056
France
33-4-94616340
lafeuillade@orange.fr
http://www.isheid.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Scientific Conference Song: A World Without AIDS here

News-ID: 199171 • Views:

More Releases from General Hospital

Two Major Pharmaceutical Companies Take the Lead for an HIV Cure
Last week more than 210 international scientists met in St Maarten for the "5th International Workshop on HIV Persistence, Reservoirs & Eradication Strategies". The principal goal of this workshop, launched for the first time in December 2003 by Professors Alain Lafeuillade (Toulon, France) and Mario Stevenson (Miami, USA) is to be a catalyst between scientists wanting to put an end at the HIV pandemic. Philipsburg, Netherlands Antilles, December 12, 2011 --

More Releases for HIV

HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication
HIV Therapeutics Market– South Africa's Aspen launches three-in-one HIV drug
Recent Developments Aspen Pharma care, a South Africa’s drug maker has launched a triple combination of tablet for the treatment of HIV in the country where the HIV virus is the most prevalent. The company's new Emdolten drug is a once a day tablet which is in the form of dolutegravir, an antiretroviral medication that balances the drug’s resistance. The company has launched Aspen Stavudine which was its first generic ARV
HIV Vaccine Market HIV Vaccine Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Human Immunodeficiency Virus (HIV) Vaccines 1.1 Overview 1.2 Antiquity of HIV Vaccine Need for the Development of HIV Vaccine Primer of HIV inside the Body 3.1 Inclusion of HIV Virus into the System 3.2 Interaction of HIV with Host 3.3 Eradication of HIV Virus HIV Vaccine Development Process 4.1 Introduction
Global HIV Vaccine Market & HIV Vaccine Clinical Trial Outlook 2022
Worldwide, around the 35 Million of the people are currently infected with the HIV and about 30 Million of the people died because of the AIDS infection. There is no human example of clearing an HIV infection naturally. HIV virus makes copies of it very quickly, many types of HIV exist and new types of virus are continue to rise. Many scientists are still trying to understand the specific ways
Hidden HIV Revealed: New Insights Into Latent HIV Infections
In spite of ever more effective therapies, HIV keeps managing to survive in the body. A comprehensive project conducted by the Austrian Science Fund FWF has clarified the molecular processes which contribute to this effect. In the process, approaches were discovered for possible therapies to combat the hidden reservoir formed by the virus. Thanks to modern therapies, HIV infections have become controllable – but these treatments cannot provide a cure. Antiretroviral